Ivermectin induced Steven-Johnsons syndrome: case report

BMC Res Notes. 2017 May 8;10(1):179. doi: 10.1186/s13104-017-2500-5.

Abstract

Background: Stevens-Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens-Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable.

Conclusion: Stevens-Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection.

Keywords: Human immunodeficiency virus (HIV); Ivermectin; Stevens–Johnson syndrome (SJS).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiparasitic Agents / adverse effects*
  • Cameroon
  • Filariasis / prevention & control
  • HIV Infections / complications
  • HIV Infections / diagnosis*
  • HIV Infections / virology
  • Humans
  • Ivermectin / adverse effects*
  • Male
  • Stevens-Johnson Syndrome / complications
  • Stevens-Johnson Syndrome / diagnosis*
  • Stevens-Johnson Syndrome / etiology

Substances

  • Antiparasitic Agents
  • Ivermectin